Introduction
============

Skin aging is caused by the following two main progressive processes: 1) intrinsic and 2) extrinsic processes.[@b1-ccid-9-435] The extrinsic process is caused by environmental aggressors, also known as "photoaging". Intrinsic and extrinsic aging (photoaging) of the skin are likely driven by similar biological and molecular mechanisms.[@b2-ccid-9-435] The formation of reactive oxygen species (ROS) and induction of matrix metalloproteinases (MMPs) are the common factors of both types of skin aging.[@b3-ccid-9-435] Skin photoaging is the result of preventable chronic exposure to ultraviolet (UV) radiation combined with intrinsic aging.[@b4-ccid-9-435] Major changes in skin photoaging occur within the dermis.

The age-related loss of cutaneous elasticity is associated with the reconstruction of the dermis extracellular matrix and an increased incidence of both skin tears and pressure ulcers.[@b5-ccid-9-435],[@b6-ccid-9-435] Varani et al[@b7-ccid-9-435] reported that reduced collagen synthesis in chronologically aged skin reflects at least two different underlying mechanisms: 1) aging of cellular fibroblasts and 2) reduced mechanical stimulation. Moreover, collagen fibers are fragmented by exposure to UV light and/or aging.[@b8-ccid-9-435]

*Aloe vera* (*Aloe barbadensis* Miller) gel is obtained from the mesophyll of the plant. *Aloe vera* gel contains polysaccharides, amino acids, lipids, plant sterols, tannins, and enzymes that have been routinely used as herbal medicines.[@b9-ccid-9-435],[@b10-ccid-9-435] Moreover, *Aloe* sterol is present in the *Aloe vera* gel and possesses a unique efficacy.[@b11-ccid-9-435] Structurally, *Aloe* sterol falls into two groups of compounds: 1) lophenol (lophenol, 24-methyl-lophenol, and 24-ethyl-lophenol) and 2) cycloartane (cycloartenol and 24-methylene-cycloartanol). *Aloe* sterol can activate the peroxisome proliferator-activated receptor (PPAR) ligands.[@b12-ccid-9-435] Barlaka et al[@b13-ccid-9-435] reported that the novel connection between PPAR signaling and MMP downregulation in cardiac myocytes might be involved in the management of oxidative stress-induced cardiac dysfunction. Furthermore, our recent study demonstrated that *Aloe* sterol significantly prevented an increase in the total protein expression of MMP-2 (active and pro) and MMP-9 (active and pro) in UVB-irradiated mice.[@b14-ccid-9-435]

Our previous study revealed that the levels of skin moisture, skin elasticity, and collagen scores in the *Aloe* sterol group were higher than those of the placebo groups.[@b15-ccid-9-435] Furthermore, ultrasound echogenicity revealed that *Aloe* sterol intake increased the amount of collagen in the dermis.

In the present study, we examined the influence of *Aloe* sterol intake on sunlight-exposed skin conditions of men who did not use sunscreen during the summer season in Japan.

Methods
=======

Trial registration
------------------

UMIN Clinical Trial Registry: UMIN000018384. Registered on July 7, 2015.

Test samples
------------

[Table 1](#t1-ccid-9-435){ref-type="table"} presents the composition of *Aloe* sterol and the control tablets. The amount of *Aloe* sterols per daily dose (five tablets) was 40 mg. The *Aloe vera* gel powder was prepared by drying the mesophyll of *Aloe vera* plants. In the placebo tablets, the *Aloe vera* gel powder was replaced with dextrin.

Study design
------------

This study was conducted as a monocentric, double-blinded, randomized, placebo-controlled supplementation study on the effects of *Aloe* sterol on skin elasticity and hydration after 12 weeks of daily *Aloe* sterol intake. The study protocol was examined and approved by the institutional review board of the Medical Corporation Bokushinkai CLINTEXE Clinic (Tokyo, Japan) and was conducted according to the guidelines of the Declaration of Helsinki 2013. Before beginning the study, written informed consent was obtained from all the participants, and they were free to withdraw from the study at any time without obligation. This study was carried out from July 2015 to October 2015, during summer to autumn in Japan.

Subjects
--------

A total of 48 apparently healthy adult Japanese men (age: 30--59 years) who were outdoors during the daytime for 2--5 hours were randomly assigned to the placebo (n=24) or *Aloe* sterol (n=24) groups. Each participant was identified by a code that was randomly selected using a computer-generated permutation procedure. The codes were sequentially allocated to the participants in the order in which they were enrolled. After all the measurements had been completed, the randomization codes were disclosed to the investigators. The study participants, investigators, staff members, and laboratory technicians were all blinded to the group assignment.

Inclusion criteria
------------------

The inclusion criteria were as follows: healthy men of age 30--59 years and individuals who were outdoors during the daytime for 2--5 hours.

Exclusion criteria
------------------

The exclusion criteria were as follows: individuals who regularly used cosmetics or consumed food that adversely affected skin conditions (e.g., hyaluronic acid, ceramide, and collagen peptide); those who used cosmetics and creams, except sunscreen on the arms; those whose arms had a skin abnormality that required treatment; those with allergic diseases with sleep deprivation or a sleep disorder; those with skin diseases; those who excessively ingest alcohol and are current smokers (smoking \>20 cigarettes per day); those with a history of serious skin, liver, kidney damage, heart, lungs, endocrine, and metabolic diseases; those with a history of drug or serious food allergy; those with simultaneous participation in other clinical studies; and those judged inappropriate for the study based on subject background, physical findings, or medical examination.

Measurement of skin parameters
------------------------------

The test areas were designated as the inner side of one forearm. The skin parameters were examined at weeks 0, 4, 8, and 12 of the treatment period. Measurements were performed under the standard conditions of room temperature (20°C--22°C) and humidity (45%--55%). The participants were allowed to adapt to the room conditions for at least 20 minutes before the examination. Each skin color index was determined using a spectrophotometer CM-2600d (Konica Minolta, Tokyo, Japan). CM-2600d was used for skin color measurement after the calibration using a certificated white plate. The *L*\* value provides the relative lightness ranging from total black (*L*\*=0) to total white (*L*\*=100); the *a*\* value represents the balance between red (positive value) and green (negative value); and the *b*\* value represents the balance between yellow (positive value) and blue (negative value).[@b16-ccid-9-435] A Corneometer CM 825 (Courage and Khazaka Electronic GmbH, Cologne, Germany) was used to determine the skin hydration level. Skin elasticity was determined using a Cutometer MPA 580 (Courage and Khazaka Electronic GmbH). The elastic measurement was evaluated according to the following parameters: R2 (gross elasticity), R5 (net elasticity), and R7 (biological elasticity). The values of skin elasticity are known to decrease with aging. We performed a stratified analysis of skin elasticity in subjects aged \<46 years (median age).

Statistical analysis
--------------------

The skin parameters were analyzed using the analysis of covariance with the treatment effect and baseline skin parameters as covariates. The differences with a *P*\<0.05 in a two-tailed *t*-test were considered to be significant.

Results
=======

Subject demographics
--------------------

A total of 48 apparently healthy men were initially enrolled into the study, none of whom met the exclusion criteria. Therefore, all 48 men were randomly assigned to the placebo (n=24) or the *Aloe* sterol (n=24) group in a double-blind manner. One participant in the *Aloe* sterol group violated compliance (20% of intake rate during 0--4 weeks) after the baseline tests. Therefore, we analyzed the data from 47 subjects. The number of subjects of the age groups 30--39, 40--49, and 50--59 years were nine, six, and nine, respectively, in the placebo group and seven, seven, and nine, respectively, in the *Aloe* sterol group. The two groups presented with comparable baseline characteristics ([Table 2](#t2-ccid-9-435){ref-type="table"}). There were no significant differences between the two groups. No significant treatment-related adverse events were reported with respect to blood lipid or biochemical parameters during the 12-week study period (data not shown).

Skin color value
----------------

The subjects included healthy adult men with the habit of being active outdoors for 2--5 hours per day in their daily life. They were instructed to discontinue the use of cosmetics, including sunscreen, at the measurement site (forearm) during the test period. We observed an increase in the melanin index values at 4, 8, and 12 weeks in the placebo group and at 4 and 12 weeks of the *Aloe* sterol group compared with that at baseline ([Table 3](#t3-ccid-9-435){ref-type="table"}). Similar to the observed changes in the melanin index values, the *b*\* values increased at 4, 8, and 12 weeks in both the placebo and *Aloe* sterol groups. In contrast, a decrease in the *L*\* values (brightness) was observed in both the placebo and *Aloe* sterol groups during the test period. There were no differences between both groups for the values of *L*\*, *a*\*, *b*\*, and the melanin index at the site used for the skin measurements. Contrary to the increase in the melanin index and *b*\* values, we observed a decrease in the skin hydration of the forearm that was exposed to sunlight at 8 and 12 weeks in both groups (data not shown).

Skin elasticity
---------------

[Table 4](#t4-ccid-9-435){ref-type="table"} shows the results of the skin elasticity parameters (R2, R5, and R7) on the forearm. The R2 parameters of the *Aloe* sterol group were higher at 8 and 12 weeks compared with the baseline values. The placebo group was higher at 12 weeks compared with the baseline values. After having taken *Aloe* sterol tablets daily for 4 weeks, the R5 level was significantly higher than the baseline value until 12 weeks. The R5 of the placebo group was also higher at 4 and 12 weeks compared with the baseline value. The R7 of the *Aloe* sterol group was higher at 4 and 12 weeks compared with the baseline value. The R7 of the placebo group was higher at 12 weeks compared with the baseline value. There was no difference between both groups in the R2, R5, and R7 values.

The values of R2, R5, and R7 are known to decrease with aging.[@b17-ccid-9-435] Therefore, we divided each group into two groups, with one including subjects \< median age (46 years) and another including subjects \> median age. We then performed a stratified analysis of subjects aged \<46 years (young placebo group: n=11 and young *Aloe* sterol group: n=12). The change in the R2 at 12 weeks (0.024%±0.009%) was significantly higher in the young *Aloe* sterol group than that of the baseline value ([Figure 1](#f1-ccid-9-435){ref-type="fig"}). In contrast, the placebo tablets did not significantly affect the change in the R2 value at 12 weeks (0.009%±0.008%). The change in the R5 of the young *Aloe* sterol group was significantly greater at 4, 8, and 12 weeks (0.075%±0.015%, 0.057%±0.016%, and 0.065%±0.022%, respectively) than the baseline value ([Figure 2](#f2-ccid-9-435){ref-type="fig"}). In contrast, the change in the R5 at 4, 8, and 12 weeks (0.033%±0.021%, 0.005%±0.017%, and 0.045%±0.021%, respectively) was not significantly affected by the placebo tablets. Furthermore, the change in the R5 was significantly higher in the *Aloe* group than in the placebo group at 8 weeks for this age group (*P*=0.0412; [Figure 2](#f2-ccid-9-435){ref-type="fig"}). The change in the R7 of the young *Aloe* sterol group was significantly greater at 4, 8, and 12 weeks (0.024%±0.005%, 0.023%±0.010%, and 0.027%±0.013%, respectively) than the baseline value. In contrast, the change in the R7 at 4, 8, and 12 weeks (0.007%±0.013%, −0.011%±0.012%, and 0.016%±0.010%, respectively) was not significantly affected by the placebo tablets. Furthermore, the change in the R7 was significantly higher in the *Aloe* sterol group than in the placebo group at 8 weeks in this age group (*P*=0.0410; [Figure 3](#f3-ccid-9-435){ref-type="fig"}).

Discussion
==========

In general, the *b*\* and *L*\* values show a significant correlation with the perception of tanning.[@b18-ccid-9-435],[@b19-ccid-9-435] During this study period, the subject was instructed that the measurement position (forearm) should be exposed to sunlight for 2--5 hours per day. Therefore, we also observed a decrease in the *L*\* value and an increase in the *b*\* value depending on the increase in the melanin index value. The midsummer months (June and August) in 2015 in Japan werê8 weeks after the study commenced, and the UV index score waŝ9 (strong) to 10 (very strong; data from the homepage of the Japan Meteorological Agency[@b20-ccid-9-435]).

Our recent clinical study suggested that the *Aloe* sterol intake induced a significant increase in the skin hydration of Japanese women's skin that was protected from sunlight by clothing.[@b15-ccid-9-435] In a basic research report, we suggested that the *Aloe* sterols prevented significant UVB irradiation-induced decreases in skin hydration, elasticity, and hyaluronic acid synthase 2 (Has2) in hairless mice.[@b14-ccid-9-435] In this study, we did not observe the preventive efficacy of *Aloe* sterol ingestion on a decrease in skin moisture by exposure to sunlight. Since the study involved the natural exposure of sunlight in accordance with the lifestyle of each subject, we were not able to ensure that each subject received the same amount of sunlight. [Table S1](#SD1-ccid-9-435){ref-type="supplementary-material"} presents the difference in the quantity of sun exposure between each subject. Thus, to examine the efficacy of the ingestion of *Aloe* sterol on skin photodamage, additional clinical studies that standardize the amount of UV rays for each subject is required.

Koyano et al[@b21-ccid-9-435] indicated that an abundance of type 4 collagen in the dermis was statistically lower in patients with skin tears than in those without skin tears. Therefore, a reduction in the dermis collagen density is associated with skin elasticity and fragility. Therefore, skin elasticity is one of the indexes of the healthy dermis structure.

Cho et al[@b22-ccid-9-435] examined the immunostaining and RT-PCR of the buttock skin of Korean women, before and after *Aloe vera* gel powder intake. The authors suggested that the ingestion of *Aloe vera* gel powder increases type 1 procollagen in human skin tissue. Moreover, *Aloe* sterol promotes collagen production and increases the synthesis of type I and type III collagen in human dermal fibroblasts.[@b23-ccid-9-435] Furthermore, our recent clinical trial demonstrated that the results of an ultrasonography evaluation suggest that the intake of 40 mg of *Aloe* sterol increased collagen score within the dermis.[@b15-ccid-9-435]

The previous study reported significant increases in the skin elasticity R2 and R7 parameters after 90 days of *Aloe vera* gel powder intake.[@b22-ccid-9-435] Similarly, the results of our recent study revealed that the dietary supplementation of 40 mg of *Aloe* sterol increased the skin parameters of R2, R5, and R7 in women.[@b16-ccid-9-435] In this study, we demonstrate that a daily oral dose of 40 mg of *Aloe* sterols significantly increased skin elasticity (R5 and R7) in men aged \<46 years compared with the placebo group.

Gerhardt et al[@b17-ccid-9-435] reported that the skin elasticity (R2, R5, and R7) of young men (age range: 17--46 years) is higher than that of older men (age range: 66--95 years). They discussed that the disintegration could explain the decrease in the biological elasticity of R7 in the elderly, the increased porosity of the elastic fibers,[@b24-ccid-9-435],[@b25-ccid-9-435] and a decrease in R5 demonstrates an impaired ability of aged skin to return to its initial state after vacuum.[@b26-ccid-9-435] The sun-protected dermis of men is much thicker than that of women (1.8-fold). In contrast, epidermal and subcutaneous tissues are thicker in women (3.5- and 10-fold, respectively).[@b27-ccid-9-435] In previous studies, the analysis of sun-protected skin obtained from young and elderly Caucasian donors revealed biomarkers of endogenous human skin aging in both genders and indicated that the process of aging in men may significantly differ from that in women.[@b28-ccid-9-435] In these subjects, a change in the skin conditions was independently affected by intrinsic and extrinsic (i.e., photoaging) processes. Therefore, additional studies are required to examine the efficacy of *Aloe* sterol in older men.

Since the skin was exposed to UV light according to the activities of everyday life for each of the subjects, this study has some limitations. There was a broad range in the amount of UV exposure for each subject. Furthermore, the ratio of subjects exposed to sunlight gradually decreased after the fourth week from the start of the study. After 8--12 weeks, the ratio that protected the prescribed time was 30% in the placebo group and 50% in the *Aloe* sterol group ([Table S1](#SD1-ccid-9-435){ref-type="supplementary-material"}). We considered that the additional examination that considered various conditions is necessary to investigate the ability to affect skin condition by intake of Aloe sterol in the subjects who are exposed to the same amount of UV rays.

Minimal erythema dose (MED) is the amount of UV radiation that will produce minimal erythema (sunburn or redness caused by engorgement of capillaries) of an individual's skin within a few hours following UV exposure. Sun protection factor (SPF) is the ratio of MED after sunscreen application and baseline (untreated) MED, whereas SPF values generally denote the efficiency of a sunscreen to protect the skin from UV radiation.[@b29-ccid-9-435] To investigate the ability of the intake of *Aloe* sterol to prevent damages to the skin caused by UV irradiation, it was considered necessary to perform MED and/or SPF tests.

UV irradiation of human skin induces ROS, leading to the activation of ROS-sensitive signaling kinases in keratinocytes and fibroblasts.[@b30-ccid-9-435]--[@b32-ccid-9-435] Previous studies suggested that *Aloe vera* has anti-inflammatory and antioxidant effects.[@b33-ccid-9-435],[@b34-ccid-9-435] *Aloe* sterol derived from *Aloe vera* may also have such anti-inflammatory and antioxidant effects, and further investigation is warranted.

The results of this double-blind clinical trial demonstrated that the daily oral intake of 40 mg *Aloe* sterol significantly increased the skin elasticity of UV-exposed men aged \<46 years.

Supplementary material
======================

###### 

Sun exposure time of subject

  Sun exposure habit (hours per day)                 Group           n    0--4 weeks, n (%)   4--8 weeks, n (%)   8--12 weeks, n (%)
  -------------------------------------------------- --------------- ---- ------------------- ------------------- --------------------
  2--5[\*](#tfn13-ccid-9-435){ref-type="table-fn"}   *Aloe* sterol   23   21 (91.3)           16 (69.6)           13 (56.5)
                                                     Placebo         24   17 (73.9)           14 (60.9)           7 (30.4)
  \<2                                                *Aloe* sterol   23   2 (8.7)             7 (30.4)            10 (43.5)
                                                     Placebo         24   7 (29)              10 (42)             17 (71)

**Note:**

Each subject was instructed to expose his arm to sunlight every day for 2--5 hours.

**Disclosure**

The authors report no conflicts of interest in this work.

![The change in the R2 (gross elasticity) of participants aged \<46 years during the treatment period.\
**Notes:** The data are expressed as mean ± SE (placebo n=12 and *Aloe* sterol n=11). \**P*\<0.05 vs baseline values.\
**Abbreviations:** AS, *Aloe* sterol; SE, standard error.](ccid-9-435Fig1){#f1-ccid-9-435}

![The change in the R5 (skin net elasticity) of participants aged \<46 years during the treatment period.\
**Notes:** The data are expressed as mean ± SE (placebo n=12 and *Aloe* sterol n=11). \**P*\<0.05, \*\**P*\<0.005 vs baseline values. ^\#^*P*\<0.05 vs placebo group values.\
**Abbreviations:** AS, *Aloe* sterol; SE, standard error.](ccid-9-435Fig2){#f2-ccid-9-435}

![The change in the R7 (skin biological elasticity) of participants aged \<46 years during the treatment period.\
**Notes:** The data are expressed as mean ± SE (placebo n=12 and *Aloe* sterol n=11). \**P*\<0.05, \*\**P*\<0.005 vs baseline values. ^\#^*P*\<0.05 vs placebo group values.\
**Abbreviations:** AS, *Aloe* sterol; SE, standard error.](ccid-9-435Fig3){#f3-ccid-9-435}

###### 

Ingredient composition of the tablets in this study

  -----------------------------------------------------------------------------------
                                                    Placebo\         *Aloe* sterol\
                                                    (mg/5 tablets)   (mg/5 tablets)
  ------------------------------------------------- ---------------- ----------------
  AVGP[\*](#tfn1-ccid-9-435){ref-type="table-fn"}   0                500

  Dextrin                                           500              0

  Citric acid                                       100              100

  Maltose                                           1417.5           1417.5

  Sour milk                                         25               25

  Cellulose                                         250              250

  Calcium phosphate                                 12.5             12.5

  Flavor                                            87.5             87.5

  Glycerin fatty acid                               50               50

  Sugar ester                                       50               50

  Food color                                        5                5
  -----------------------------------------------------------------------------------

**Note:**

AVGP (500 mg) contains 40 mg of *Aloe* sterol.

**Abbreviation:** AVGP, *Aloe vera* gel powder.

###### 

Demographic and baseline characteristics

  ----------------------------------------------------------------
  Characteristic                    Placebo\      *Aloe* sterol\
                                    (n=24)        (n=23)
  --------------------------------- ------------- ----------------
  Age (years)                       44.6±8.7      45.4±8.5

  Height (cm)                       170.07±4.03   170.76±5.54

  Body weight (kg)                  64.65±6.61    65.07±9.02

  BMI                               22.33±1.97    22.31±2.80

  Systolic blood pressure (mmHg)    119.1±12.3    123.0±12.7

  Diastolic blood pressure (mmHg)   75.9±8.2      75.7±9.5

  Pulse rate (bpm)                  63.8±11.3     61.7±8.8
  ----------------------------------------------------------------

**Notes:** Data are expressed as mean ± SD. There were no significant differences in the skin parameters between the two groups.

**Abbreviations:** BMI, body mass index; SD, standard deviation.

###### 

Skin color values

  Item                                                   Group           n    0 week          4 weeks                                                      8 weeks                                                      12 weeks
  ------------------------------------------------------ --------------- ---- --------------- ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------
  *L*[\*](#tfn6-ccid-9-435){ref-type="table-fn"} value   *Aloe* sterol   23   62.56±4.87      61.69±4.71[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}      61.95±4.13                                                   61.93±3.82
                                                         Placebo         24   61.88±2.94      60.43±3.14[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}      60.68±2.52[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}      60.93±2.24[\*](#tfn6-ccid-9-435){ref-type="table-fn"}
  *a*[\*](#tfn6-ccid-9-435){ref-type="table-fn"} value   *Aloe* sterol   23   6.21±2.28       6.48±2.00                                                    6.20±1.99                                                    6.80±1.93
                                                         Placebo         24   6.43±1.48       7.19±1.61[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}       6.80±1.38                                                    7.26±1.38[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}
  *b*[\*](#tfn6-ccid-9-435){ref-type="table-fn"} value   *Aloe* sterol   23   16.59±2.30      17.02±2.39[\*](#tfn6-ccid-9-435){ref-type="table-fn"}        17.22±2.26[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}      17.80±2.04[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}
                                                         Placebo         24   17.02±1.77      17.81±1.64[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}      17.75±1.42[\*](#tfn6-ccid-9-435){ref-type="table-fn"}        18.22±1.34[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}
  Melanin index                                          *Aloe* sterol   23   0.9239±0.3105   0.9807±0.3162[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}   0.9645±0.2936                                                1.0080±0.2624[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}
                                                         Placebo         24   0.9557±0.2028   1.0677±0.2142[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}   1.0371±0.1691[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}   1.0628±0.1466[\*\*](#tfn7-ccid-9-435){ref-type="table-fn"}

**Notes:** The skin color index was determined using a spectrophotometer at the forearm. Data are expressed as mean ± SD.

*P*\<0.05,

*P*\<0.005 different from week 0.

**Abbreviation:** SD, standard deviation.

###### 

Analysis results of the skin elasticity parameters (R2, R5, and R7) on the forearm

  Item                            Group           n             0 week                                                    4 weeks                                                     8 weeks                                                     12 weeks
  ------------------------------- --------------- ------------- --------------------------------------------------------- ----------------------------------------------------------- ----------------------------------------------------------- -----------------------------------------------------------
  R2 (%, gross elasticity)        *Aloe* sterol   23            0.823±0.029                                               0.835±0.037                                                 0.837±0.035[\*](#tfn10-ccid-9-435){ref-type="table-fn"}     0.843±0.043[\*](#tfn10-ccid-9-435){ref-type="table-fn"}
  Placebo                         24              0.822±0.054   0.827±0.039                                               0.826±0.042                                                 0.837±0.044[\*](#tfn10-ccid-9-435){ref-type="table-fn"}     
  R5 (%, net elasticity)          *Aloe* sterol   23            0.760±0.053                                               0.819±0.090[\*\*](#tfn11-ccid-9-435){ref-type="table-fn"}   0.808±0.058[\*\*](#tfn11-ccid-9-435){ref-type="table-fn"}   0.826±0.076[\*\*](#tfn11-ccid-9-435){ref-type="table-fn"}
  Placebo                         24              0.748±0.091   0.784±0.098[\*](#tfn10-ccid-9-435){ref-type="table-fn"}   0.772±0.100                                                 0.815±0.111[\*](#tfn10-ccid-9-435){ref-type="table-fn"}     
  R7 (%, biological elasticity)   *Aloe* sterol   23            0.553±0.038                                               0.569±0.051[\*](#tfn10-ccid-9-435){ref-type="table-fn"}     0.568±0.046                                                 0.575±0.060[\*](#tfn10-ccid-9-435){ref-type="table-fn"}
  Placebo                         24              0.546±0.067   0.555±0.066                                               0.546±0.066                                                 0.570±0.068[\*](#tfn10-ccid-9-435){ref-type="table-fn"}     

**Notes:** R2, R5, and R7 values were determined using a Cutometer on the forearm. Data are expressed as mean ± SE.

*P*\<0.05,

*P*\<0.005, different from week 0.

**Abbreviation:** SE, standard error.
